ARGX
arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B round
Wednesday, November 30, 2011 BiopharmaWatch Research 1 min read Key Takeaway: arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B round
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+36%
120-day peak, hindsight
Typical move
4.7%
average across 12 past catalysts
Lead asset
Empasiprubart
Phase 2 · AChR-Ab Seropositive Generalized Myasthenia Gravis
Full Press Release Details
arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B round.